Making a difference: The role of technology in fighting, treating and living with cancer
According to the World Health Organization, one in six deaths in the world is due to cancer. In 2018, an estimated 1,735,350 new cases of cancer will be diagnosed in the United States and more than 600,000 will die from the disease. The national expenditure for cancer care in 2017 were $147.3 billion, and that cost is projected to increase as the population ages. It is no wonder that this year’s Nobel Prize for medicine went to two cancer researchers for discoveries that have revolutionized cancer care.
New technologies continue to emerge at lightning speed, providing empowerment and better disease management for patients and new tools for clinicians, researchers and caregivers. As a tech and research hub, Seattle is becoming a hot bed for research and innovation in cancer therapies, data-driven prevention and management solutions and holistic integrated approaches to patient care. Join experts from KenSci, MoleMapper, SageBionetworks and Seattle Children’s Research Institute to discuss the role technology can play in fighting, treating and living with cancer
Abby R. Rosenberg, MD, MS, MA, is a Professor of Pediatrics at the University of Washington, with joint appointments in the divisions of Bioethics & Palliative Care, and Hematology/Oncology. She received her MD from Stanford University and did her pediatrics residency and fellowship training at Seattle Children’s and the University of Washington.
She is the director of the “Palliative Care and Resilience” research at Seattle Children’s Research Institute. Her work focuses on the intersection of medical, psychosocial, and bioethical issues involved in the care of adolescents and young adults (AYAs) with serious illness. Specifically, she and her team endeavor to create scalable interventions to promote patient and family resilience.
Ankur M. Teredesai, Ph.D., is the co-founder and Chief Technology Officer of KenSci. He also holds a Professorship in Computer Science & Systems at the University of Washington. His research spans data science with its applications for societal impact in healthcare. Apart from his academic appointments at RIT and the University of Washington, Teredesai has significant industry experience, having held various positions at C-DAC Pune, Microsoft Research, IBM T.J. Watson Labs, and a variety of technology startups. He has published over 75 papers on machine learning, has managed large teams of data scientists and engineers, and deployed data science solutions in healthcare. His recent applied research contributions include cost and risk prediction for readmission due to chronic conditions such as congestive heart failure. Other applications of his work have enabled predicting lengths of stay and sepsis as well as predicting medication pathways to lower risks of mortality and rehospitalization.
He is the Executive Director of Center for Data Science, and serves as the Information Officer for ACM SIGKDD (Special Interest Group in Knowledge Discovery and Data Mining) the leading organization of industry and academic researchers in data science. He is currently an associate editor for ACM SIGKDD Explorations and IEEE Transactions on Big Data and serves on program committees of major international conferences in machine learning and healthcare.
Dan Webster is the Principal Scientist of Digital Health for Sage Bionetworks, a non-profit research organization, where he conducts app-based remote research studies to detect and manage disease. Dan designed, implemented, and deployed the original iOS app-based Mole Mapper Melanoma Study, which uses the iPhone camera to quantitatively track potential pre-cancerous lesions over time. He was recognized with a 2017 STATNews Wunderkind Award for his work in digital health research. His scientific training spanned from the University of Wisconsin-Madison (Genetics) and Stanford (Cancer Biology), followed by training as a Damon Runyon Postdoctoral Research Fellow at the National Cancer Institute. His research combined genome engineering and bioinformatics to discover and functionally assess novel non-coding genes and regulatory elements in skin and hematologic cancers. Alongside his ongoing research, Dan currently serves as a scientific lead for the Digital Health Technology effort in the Precision Medicine Initiative's million-person, longitudinal 'All of Us' Research Program.
Sara Gosline, PhD is a Senior Research Scientist at Sage Bionetworks leading diverse research communities to increase collaboration via data curation and establish standards of data sharing. She also collaborates with bench scientists to enable computational integration of diverse datasets across large teams of scientist with oncology and rare disease. Specifically she works to bring computational systems biology approaches to study Neurofibromatosis, a cancer-causing syndrome that effects 1 in 3000 people and currently has no approved treatment.
Emilia Palaveeva is a consultant, working at the intersection of technology, business, and design, to help companies identify areas where innovation can make a difference. Previously, she led marketing and business development strategy at Artefact, and led global marketing campaigns for Fortune 500 clients and breakthrough emerging technology startups.
Details for the next event are still being worked out! Check back soon.